Fresenius Medical Care | FME - 营业费用

金融业

EUR

EUR 31.29B

现金及等价物

EUR 1.06B

EUR 3.55B

EUR 7.69B

EUR 7.18B

EUR 10.96B

股息收益率

3.76

EUR 480.55M

EUR 843.66M

112.38K

EPS每股收益

EUR 1.12

股本和储备

EUR 13.53B

EUR 1.31B

债务利息支出

EUR 83M

EUR 14.7M

EUR 5.82B

EUR 11.62B

EUR 218.38M

EUR 4.32B

EUR 537.27M

普通股股本

EUR 266.11M

12.13

EUR 383M

EUR 4.86B

销售和管理费用

EUR 736.01M

EUR 2.33B

贸易债权人

EUR 891.84M

应收帐款人

EUR 3.47B

	营业费用	更改		日
Akzo Nobel	EUR 2.34B		206M	2026-06
Alcon AG	USD 2.78B		370M	2026-06
AstraZeneca	USD 12.22B		4.04B	2026-06
Bayer	EUR 10.04B		168M	2026-06
Beiersdorf	EUR 4.16B		212M	2025-12
DaVita Healthcare Partners	USD -765.1M		9.6M	2026-06
Demant	DKK 10.79B		1.16B	2026-06
E.ON	EUR 15.11B		2.6B	2026-06
Essilor	EUR 12.52B		568M	2026-06
Fresenius	EUR 5.23B		9M	2026-06
Fresenius Medical Care	EUR 4.32B		20.7M	2026-06
Genmab	DKK 748M		77M	2026-06
Getinge	SEK 7.03B		2.96B	2026-06
Givaudan	CHF 3B		107M	2025-12
GlaxoSmithKline	GBP 5.8B		468M	2026-06
GN Store Nord	DKK 2.11B		51M	2026-06
GRIFOLS	EUR 1.55B		94M	2026-06
Hikma Pharmaceutical	USD 1.34B		702M	2025-12
Lonza	CHF 2.9B		184M	2025-06
Merck	EUR 4.34B		249M	2026-06
Novartis	USD 10.2B		912M	2026-06
Philips	EUR 3.75B		147M	2026-06
Roche Holding	CHF 18.9B		2.12B	2026-06
RWE	EUR 1.96B		2.47B	2026-06
Sanofi	EUR 9.92B		607M	2026-06
SAP	EUR 7.24B		11.46B	2026-06
Smith & Nephew	USD 2.59B		71M	2026-06